194 related articles for article (PubMed ID: 38152849)
61. Cyclin D1-dependent kinase activity in murine development and mammary tumorigenesis.
Landis MW; Pawlyk BS; Li T; Sicinski P; Hinds PW
Cancer Cell; 2006 Jan; 9(1):13-22. PubMed ID: 16413468
[TBL] [Abstract][Full Text] [Related]
62. Uracil nucleotide synthesis in a human breast cancer cell line (MCF-7) and in two drug-resistant sublines that contain increased levels of enzymes of the de novo pyrimidine pathway.
Karle JM; Cowan KH; Chisena CA; Cysyk RL
Mol Pharmacol; 1986 Aug; 30(2):136-41. PubMed ID: 2874477
[TBL] [Abstract][Full Text] [Related]
63. Cyclin D1/cdk4 can interact with E2F4/DP1 and disrupts its DNA-binding capacity.
Scimè A; Li L; Ciavarra G; Whyte P
J Cell Physiol; 2008 Mar; 214(3):568-81. PubMed ID: 17894419
[TBL] [Abstract][Full Text] [Related]
64. Mutually exclusive cyclin-dependent kinase 4/cyclin D1 and cyclin-dependent kinase 6/cyclin D2 pairing inactivates retinoblastoma protein and promotes cell cycle dysregulation in multiple myeloma.
Ely S; Di Liberto M; Niesvizky R; Baughn LB; Cho HJ; Hatada EN; Knowles DM; Lane J; Chen-Kiang S
Cancer Res; 2005 Dec; 65(24):11345-53. PubMed ID: 16357141
[TBL] [Abstract][Full Text] [Related]
65. Vitamin C inhibits benzo[a]pyrene-induced cell cycle changes partly via cyclin D1/E2F pathway in human embryo lung fibroblasts.
Gao A; Liu BC; Shit XL; Huang CS; Jia XW; You BR; Ye M; Shen FH; Du HJ
Biomed Environ Sci; 2006 Jun; 19(3):239-44. PubMed ID: 16944783
[TBL] [Abstract][Full Text] [Related]
66. Peroxisome proliferator-activated receptor gamma activation modulates cyclin D1 transcription via beta-catenin-independent and cAMP-response element-binding protein-dependent pathways in mouse hepatocytes.
Sharma C; Pradeep A; Pestell RG; Rana B
J Biol Chem; 2004 Apr; 279(17):16927-38. PubMed ID: 14764597
[TBL] [Abstract][Full Text] [Related]
67. Formononetin promotes cell cycle arrest via downregulation of Akt/Cyclin D1/CDK4 in human prostate cancer cells.
Li T; Zhao X; Mo Z; Huang W; Yan H; Ling Z; Ye Y
Cell Physiol Biochem; 2014; 34(4):1351-8. PubMed ID: 25301361
[TBL] [Abstract][Full Text] [Related]
68. Nuclear cyclin D1: an oncogenic driver in human cancer.
Kim JK; Diehl JA
J Cell Physiol; 2009 Aug; 220(2):292-6. PubMed ID: 19415697
[TBL] [Abstract][Full Text] [Related]
69. Hijacking of nucleotide biosynthesis and deamidation-mediated glycolysis by an oncogenic herpesvirus.
Wan Q; Tavakoli L; Wang TY; Tucker AJ; Zhou R; Liu Q; Feng S; Choi D; He Z; Gack MU; Zhao J
Nat Commun; 2024 Feb; 15(1):1442. PubMed ID: 38365882
[TBL] [Abstract][Full Text] [Related]
70. [The activation of MAPK/cyclin D1-CDK4 signaling pathway caused by quartz].
Shen FH; Fan XY; Liu BC; Jia XW; Gao A; You BR; Ye M; DU HJ; Huang CS; Shi XL
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2007 Jan; 25(1):5-10. PubMed ID: 17374178
[TBL] [Abstract][Full Text] [Related]
71. Cyclin D1-CDK4 complex, a possible critical factor for cell proliferation and prognosis in laryngeal squamous cell carcinomas.
Dong Y; Sui L; Sugimoto K; Tai Y; Tokuda M
Int J Cancer; 2001 Jul; 95(4):209-15. PubMed ID: 11400112
[TBL] [Abstract][Full Text] [Related]
72. Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function.
Foster JS; Henley DC; Bukovsky A; Seth P; Wimalasena J
Mol Cell Biol; 2001 Feb; 21(3):794-810. PubMed ID: 11154267
[TBL] [Abstract][Full Text] [Related]
73. Iron overload promotes Cyclin D1 expression and alters cell cycle in mouse hepatocytes.
Troadec MB; Courselaud B; Détivaud L; Haziza-Pigeon C; Leroyer P; Brissot P; Loréal O
J Hepatol; 2006 Feb; 44(2):391-9. PubMed ID: 16229922
[TBL] [Abstract][Full Text] [Related]
74. Cyclin D1 promotes mitogen-independent cell cycle progression in hepatocytes.
Albrecht JH; Hansen LK
Cell Growth Differ; 1999 Jun; 10(6):397-404. PubMed ID: 10392901
[TBL] [Abstract][Full Text] [Related]
75. Hypertonic stress regulates amino acid transport and cell cycle proteins in chick embryo hepatocytes.
Bruscalupi G; Massimi M; Spagnuolo S; Fiore AM; Leoni S
Cell Biol Int; 2012 Feb; 36(2):203-13. PubMed ID: 21906028
[TBL] [Abstract][Full Text] [Related]
76. Neoplastic hepatocyte growth associated with cyclin D1 redistribution from the cytoplasm to the nucleus in mouse hepatocarcinogenesis.
Yamamoto M; Tamakawa S; Yoshie M; Yaginuma Y; Ogawa K
Mol Carcinog; 2006 Dec; 45(12):901-13. PubMed ID: 17013836
[TBL] [Abstract][Full Text] [Related]
77. Diversion of aspartate in ASS1-deficient tumours fosters de novo pyrimidine synthesis.
Rabinovich S; Adler L; Yizhak K; Sarver A; Silberman A; Agron S; Stettner N; Sun Q; Brandis A; Helbling D; Korman S; Itzkovitz S; Dimmock D; Ulitsky I; Nagamani SC; Ruppin E; Erez A
Nature; 2015 Nov; 527(7578):379-383. PubMed ID: 26560030
[TBL] [Abstract][Full Text] [Related]
78. Evidence that cyclin D1 mediates both growth and proliferation downstream of TOR in hepatocytes.
Nelsen CJ; Rickheim DG; Tucker MM; Hansen LK; Albrecht JH
J Biol Chem; 2003 Feb; 278(6):3656-63. PubMed ID: 12446670
[TBL] [Abstract][Full Text] [Related]
79. Functional consequences of cyclin D1/BRCA1 interaction in breast cancer cells.
Kehn K; Berro R; Alhaj A; Bottazzi ME; Yeh WI; Klase Z; Van Duyne R; Fu S; Kashanchi F
Oncogene; 2007 Aug; 26(35):5060-9. PubMed ID: 17334399
[TBL] [Abstract][Full Text] [Related]
80. Different patterns of cyclin D1/CDK4-E2F-1/4 pathways in human embryo lung fibroblasts treated by benzo[a]pyrene at different doses.
Ye M; Liu BC; Shi XL; You BR; Du HJ; Jia XW; Shen FH
Biomed Environ Sci; 2008 Feb; 21(1):30-6. PubMed ID: 18478976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
